Kim Tae Kyoo, Lee Sangjoon, Im Heh-In
Center for Brain Function, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Korea.
Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology, Seoul, Korea.
Int Neurourol J. 2022 Nov;26(Suppl 2):S117-125. doi: 10.5213/inj.2244256.128. Epub 2022 Nov 30.
The purpose of this study was to analyze the transcriptomic changes in the striatum of amyloid precursor protein/presenilin 1 (APP/PS1) transgenic mice and uncover its association with the methyl-CpG binding protein 2 (MeCP2) mediated-changes in striatal epigenetic signature during Alzheimer disease (AD) pathological progression.
To observe transcriptomic alterations in the striatum before the onset of cognitive impairment in APP/PS1 mice, quantitative 3'mRNA sequencing was performed with RNA extracted from the striatum of 6-month-old and 12-month-old wildtype and APP/PS1 mice. In addition, chromatin immunoprecipitation sequencing was conducted with the DNA from wildtype and APP/PS1 mice of the same age as aforementioned. For transcriptomic analysis, comparison terms were constructed based on aging and transgene expression-normal-aging (12-month-old wildtype/6-month-old wildtype), early-AD (6-month-old APP/PS1/6-month-old wildtype), and late-AD (12-month-old APP/PS1/6-month-old wildtype). To compare the changes in biological pathways and networks, we analyzed gene lists from each comparison term via bioinformatics tools including DAVID (Database for Annotation, Visualization, and Integrated Discovery), STRING (Search Tool for the Retrieval of Interacting Genes/Proteins), and SynGO (Synaptic Gene Ontologies). Furthermore, to assume the effect MeCP2 in AD pathological conditions may have on the transcriptome regulation, analysis of the common genes from Quant-Seq and MeCP2-ChIP-Seq was performed.
Enriched pathways including immune system and inflammatory response were confirmed in normal- aging and lateAD, respectively. In particular, enriched pathways of gene expression regulation, transcriptional regulation, and protein catabolic pathways were found to be significantly altered in early-AD. MeCP2-bound genes that were significantly altered in the transcriptome were suggested to be target genes that have a role in the striatum of the early-stage AD model.
This study confirmed that the alteration of the striatal transcriptomic profile in APP/PS1 mice was involved with several biological pathways. Additionally, comparative analysis of the transcriptomic changes and the MeCP2 bound regions found that a group of differentially expressed genes may be regulated under the epigenetic control of MeCP2.
本研究旨在分析淀粉样前体蛋白/早老素1(APP/PS1)转基因小鼠纹状体中的转录组变化,并揭示其与阿尔茨海默病(AD)病理进展过程中甲基化CpG结合蛋白2(MeCP2)介导的纹状体表观遗传特征变化之间的关联。
为观察APP/PS1小鼠认知障碍发作前纹状体中的转录组改变,对6月龄和12月龄野生型及APP/PS1小鼠纹状体提取的RNA进行了定量3'mRNA测序。此外,对与上述相同年龄的野生型和APP/PS1小鼠的DNA进行了染色质免疫沉淀测序。对于转录组分析,基于衰老和转基因表达构建了比较组——正常衰老(12月龄野生型/6月龄野生型)、早期AD(6月龄APP/PS1/6月龄野生型)和晚期AD(12月龄APP/PS1/6月龄野生型)。为比较生物途径和网络的变化,我们通过包括DAVID(注释、可视化和综合发现数据库)、STRING(相互作用基因/蛋白质检索搜索工具)和SynGO(突触基因本体)在内的生物信息学工具分析了每个比较组的基因列表。此外,为推测MeCP2在AD病理条件下可能对转录组调控产生的影响,对定量测序(Quant-Seq)和MeCP2染色质免疫沉淀测序(MeCP2-ChIP-Seq)中的共同基因进行了分析。
正常衰老和晚期AD分别证实了包括免疫系统和炎症反应在内的富集途径。特别是,在早期AD中发现基因表达调控、转录调控和蛋白质分解代谢途径的富集途径有显著改变。转录组中显著改变的MeCP2结合基因被认为是在早期AD模型纹状体中起作用的靶基因。
本研究证实APP/PS1小鼠纹状体转录组谱的改变与多种生物途径有关。此外,对转录组变化和MeCP2结合区域的比较分析发现,一组差异表达基因可能在MeCP2的表观遗传控制下受到调控。